AI Article Synopsis
- - LX9211 showed significant pain reduction in diabetic peripheral neuropathy (DPN) patients during a multicenter trial, with noticeable relief reported by the first week at a 10 mg dose.
- - Higher doses of LX9211 were less effective, but side effects like dizziness and nausea were mostly mild.
- - The results underscore the need to investigate both drug-based and natural treatment options, like flavonoids, for managing DPN.
Article Abstract
In a multicenter trial, LX9211 significantly reduced pain in diabetic peripheral neuropathy (DPN) patients, with the 10 mg dose showing notable relief by the first week. Although the higher dose was less effective, side effects like dizziness and nausea were generally mild. These findings highlight the importance of exploring both pharmaceutical and natural treatments, such as flavonoids, for managing DPN.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jdi.14342 | DOI Listing |
Publication Analysis
Top Keywords
diabetic peripheral
8
lx9211 rising
4
rising star
4
star relieving
4
relieving diabetic
4
peripheral neuropathic
4
neuropathic pain
4
pain multicenter
4
multicenter trial
4
trial lx9211
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!